Security key
29273B302
ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA)
CUSIP: 29273B302
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,186,300
- Total 13F shares
- 131,154
- Share change
- -9,563
- Total reported value
- $277,256
- Price per share
- $2.12
- Number of holders
- 11
- Value change
- -$9,387
- Number of buys
- 6
- Number of sells
- 4
Report period
Q4 2023
Institutions
11
Top holders
10
NDRA full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
ENDRA Life Sciences Inc. SEC filings
ENDRA Life Sciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29273B302
Recent filing periods:
Top shareholders of NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.2%
|
49,367
|
$55,324 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
38,939
|
$43,226 | — | 30 Sep 2023 | |
| NewEdge Advisors, LLC |
13F
|
Company |
2.7%
|
32,065
|
$35,602 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.87%
|
10,323
|
$11,000 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.63%
|
7,427
|
$8,244 | — | 30 Sep 2023 | |
| VALLEY NATIONAL ADVISERS INC |
13F
|
Company |
0.07%
|
869
|
$1,000 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.07%
|
788
|
$883 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
781
|
$867 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
103
|
$114 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
55
|
$61 | — | 30 Sep 2023 | |
| Michael Milos Thornton |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
34,139
|
$56,329 | — | 18 May 2023 | |
| Renaud Bertrand Maloberti |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
186,430
|
— | — | 28 Mar 2022 | |
| Francois Roger Michelon |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
69,531
|
— | — | 30 Jan 2023 | |
| Irina Pestrikova |
3/4/5
|
Senior Director, Finance |
—
class O/S missing
|
8,000
|
— | — | 30 Jan 2023 |
Institutional Holders of ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) as of Q4 2023
As of 31 Dec 2023,
ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
131,154 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, NewEdge Advisors, LLC, JPMORGAN CHASE & CO, Tower Research Capital LLC (TRC), VALLEY NATIONAL ADVISERS INC, MORGAN STANLEY, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, BlackRock Inc., and WELLS FARGO & COMPANY/MN.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
10
Q4 2023 holders
11
Holder diff
1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.